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Abstract. Antibiotic resistance is a great burden from medicinal and 
economic point of view, which stems from the overprescription and 
misuse of anti-infective drugs. It is further aggravated by the horizontal 
spread of resistance genes between bacterial species and genera. The 
increasing rate of antibiotic resistance of bacteria urges new attempts to 
overcome the problem. Antimicrobial agents with new mechanisms 
resistance modifiers of synthetic or natural origin would serve an 
alternative way of antimicrobial chemotherapy targeting the inhibition 
of bacterial growth and the spread of antibiotic resistance. 
      This review reports the biological properties of essential oils and 
other plant derived compounds with special regard to their anti-
infective features and resistance modifier activity, including 
antibacterial (gram-positive, gram-negative bacteria and Mycobacteria), 
antiplasmid  activities both in vitro and in vivo. 
 
Introduction 
 
 Medicinal plants have been used for thousands of years; in the ancient 
times, plant remedies provided the medicinal armamentarium in the treatment 
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of diverse ailments. There is ample archaeological evidence that people of 
prehistoric time regularly employed medicinal plants, therefore the 
application of herbal drugs can be considered universal from the very early 
ages. Some of the earliest known written records deal with the subject of 
healing with medicinal substances. The ancient Egyptians of 3000 to 6000 
years ago are credited with developing an elaborate and effective 
pharmacological collection of numerous curing materials obtained from 
natural resources. In the ancient Greece, Dioscorides is noted for assembling 
24 detailed books on over 600 curative plants and their proper uses under the 
title De Materia Medica, the earliest known designation of that terminology 
[1]. The system of herbal medicine is built on the rich experience in use of 
herbs, and this knowledge has been accumulated since the birth of Chinese 
culture more than 2000 years ago. Thus, plants have an advantage that their 
application is based on long-term use by humans, often hundreds or 
thousands of years. The number of studies and surveys of which results can 
give sufficient information about the adverse effects and toxicity of legendary 
herbal remedies is increasing, due to the extended awareness and interest in 
complementary and alternative medicine. This trend can be attributed to 
several factors: dissatisfaction of patients with the high costs and potentially 
hazardous side effects of factory-made pharmaceuticals, wide availability of 
complementary medicinal products, which are often used in self-reported 
health problems without consultation with a health professional, the 
misconception about herbal remedies in terms of side effects and safely use. 
Nearly 1 in 5 people in the US population report using a herb for treatment of 
health conditions and/or health promotion. More than half did not disclose 
this information to their physician according to the 2002 National Health 
Interview Survey in the USA [2]. Based on the presence or absence of 
scientific evidence, there are two groups of how herbal products may be used: 
traditional use with limited documentation and established use, which is 
supported by scientific evidences [3]. Since most of the herbal drugs are Over 
The Counter (OTC) drugs and are obtainable at herbal drug suppliers, the 
established use would be the proper approach, therefore the elucidation of safety, 
toxicity, proper dosage, contamination, potential interactions with synthetic and 
other natural drugs and possible hazards would be essential [4,5]. 
 Medicinal plants have always provided a stable source for medicines. 
Not only the herbs themselves but certain plant-derived compounds have 
served as lead molecules for further chemical modulation and natural 
products still continue to play a highly significant role in drug discovery and 
development process [6]. Herbal drugs have the advantage that they were 
used on a regular basis in the past and those products are still available in the 
same drug formulation (teas, lotions, powders, ointments, emollients, oils, 
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dressings, cleansers) and plants, especially those with ethnopharmacological 
uses, have been the primary sources of medicines for early drug discovery 
[7,4]. It was proved by a study that 122 compounds of defined structure, 
obtained from only 94 species of plants, that are used globally as drugs and 
demonstrated that 80% of these had an ethnomedical use identical or related 
to the current use of the active element of the plant. Because these 
compounds are derived from only 94 species of plants, and a conservative 
estimate of the number of flowering plants occurring on the planet is 
250,000, there should be an abundance of drugs, remaining to be discovered 
in these plants, which are hidden in undiscovered rain forests and in the 
oceans [8]. Several plants are part of our diet, which may exert medicinal 
properties as well. In addition, there is a sharp increase in the use of dietary 
supplements and great deals of them have a plant origin, however this field is 
understudied and there are not efficient food regulations. Therefore, the 
growing concern of food safety also necessitates the broader establishment of 
the biological activities and toxicity of herbs and plant derived purified 
compounds. Furthermore, there are clear trends to show that the mainstream 
in pharmaceutical research is moving away from single molecule or single 
target approach to combination and multiple target approaches, and for these 
attempt substances of natural origin are proved appropriate resource [9]. 
 Essential oils are broadly studied of their anti-infective properties, of which 
importance is supported by their availability. Since essential oils are used in 
external and internal medicinal products, and are widely used in aromatherapies, 
in cosmetics as fragrances, there is a demand on a profound knowledge of their 
activities. In vitro experiments showed that certain essential oils and purified 
components are able to act against resistance mechanisms in bacteria and tumor 
cells via plasmid curing and inhibition of efflux processes. The available data in 
this respect are limited; therefore it would be worthwhile to establish a broader 
research in this field. The increasingly growing rate of antibiotic resistance of 
microorganisms necessitates the development and research of new antimicrobial 
agents or resistance modifiers. The kingdom of plants still provides a wide source 
for new drugs, therefore substances of herbal origin with antimicrobial properties 
may be potential candidates for the development of new anti-infective agents. 
Reversal of multidrug resistance may be another attempt to mitigate the spread of 
resistance. One approach is to interfere with the genetic material of bacteria, i.e. 
bacterial plasmids, which may encode the antibiotic resistance mechanisms. 
Terpenes of essential oils extracted from different herbs are proved to have 
antimicrobial activity, and some of them may act as resistance modifiers. 
 The purpose of the present article is to review previously published and 
original data on the antimicrobial activities of the most common essential oils 
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and purified components of these plant secondary metabolites, in order to 
sum up the versatile profile of their effectivity. 
 
Antimicrobial effects of plant extracts and plant derived 
compounds  
 
 Several plants exert antimicrobial activity, however this effect is much 
more pronounced when its crude extracts or purified components are studied. 
Most available data about the antimicrobial effect of a herb or plant extract 
are based on in vitro studies, but several herbs are used due to its 
antimicrobial effects in the complementary- or ethnomedicine based on 
empirical application in vivo [10]. Several Ayurvedic drugs have been 
investigated by Gautam et al and it was revealed that the ethnomedical use of 
herbal remedies for Mycobacterium related infection strongly correlated with 
their in vitro antibacterial activity against M. tuberculosis [11].  
 The main disadvantage of the results of in vitro studies that it is difficult to 
compare to each other because of the different test methods, different methods of 
extraction, test assays, and variation in chemical phytoconstituents in plants due 
to different agroclimatic conditions and plant phenotype.  
 Shan et al investigated a series of dietary spices and herbal medicines in 
order to establish their antibacterial effects against bacteria, of which 
infections are related to food poisoning. Results emphasized that phenolic 
compounds significantly contributed to the antibacterial activity of the 
studied herbs [12]. This activity may be attributed to the enzyme inhibition 
by the more oxydized phenolic compounds possibly through reaction with 
sulfhydryl compounds or through more non-specific interactions with the 
protein. Cinnamic acid, caffeic acid, catechol and pyrogallol were shown to 
be toxic to microorganisms [13].  
 A great deal of flavonoids are synthesised by plants to fight against 
bacterial infections, therefore it is no surprise that they exert in vitro 
antimicrobial activity. Their effectivity is possibly due to their ability to form 
complex with extracellular soluble proteins and with bacterial cell walls 
[14,15]. Catechins deserve special mention, since they considerably 
contribute to the beneficial effects of oolong green teas. Beside their versatile 
activities, catechins exert antibacterial effects as well via DNA gyrase 
inhibition. Specific binding of selected catechins were proved to bind to the 
N-terminal fragment of gyrase B [16]. Furthermore, catechins are able to 
restore the susceptibility of resistance bacteria to different antibiotics e.g. 
tetracycline and beta-lactams, beta-lactamase inhibitors [17,18,19]. Tannins 
are polymeric water-soluble phenols that are common in higher herbaceous 
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and woody plants. Tannins are known of their free radical scavenging activity 
and have antibacterial effects [20]. Hydrolysable tannins have antibacterial 
potential against Helicobacter pylori and it seems promising in the 
eradication of the bacterium without affecting intestinal bacterial flora [21]. 
Oligomeric proanthocyanidines are mainly used in vascular diseases and it is 
based on their ability to trap lipid peroxides and free radicals and that they 
non-competitively inhibit xanthine oxidase, which is a major generator of 
free radicals [22,23].  
 Among plant peptides, thionines have toxic effects on different gram-
positive and gram-negative pathogenic bacteria. Fabatins, which are recently 
identified peptide molecules from fava beans appeared to inhibit the growth 
of E. coli and P. aeruginosa [24]. The tea and petroleum extract of St John’s 
wort (Hypericum perforatum) were proved to have antibacterial effect against 
methicillin resistant Staphylococcus aureus strains, which are among the 
most common and most problematic resistant strains to eradicate. Most 
probably, hyperforin may be responsible for the beneficial effects, which is 
one of the active agents responsible for the antidepressant activity [25].  
 The fruit of Malpighia emarginata DC (Malpighiaceae) is called 
barbados cherry or acerola fruit. This healthy foodstuff is nutritionally 
attractive since it contains high amounts of vitamin C, beta-carotene, 
minerals, plant fibre and small amount of vitamin B. The extracts of the fruit 
has been used as folk medicines and shows biological effects including 
antioxidant activity for the prevention of age-related diseases. Motohashi              
et al examined the antibacterial and antifungal activity of the previously 
successively extracted fruit and found that the components extracted with 
acetone showed higher activity against S. aureus, while buthanol extracts had 
more pronounced antimicrobial effect against Candida albicans. The hexane 
extracts were effective against Helicobacter pylori with minimal inhibitory 
concentrations (MICs) between 17-27 µg/mL [26]. Similarly, to acerola fruit, 
the hypophasic and epiphasic extracts of the ripe fruit of spice paprika, 
Capsicum annuum and Valencia orange and Golden delicious apples were 
investigated. These extracts displayed potent anti-H. pylori activity with 
MICs comparable with metronidazole. In an in vitro study, the extracts of a 
special variant of Capsicum annuum was examined: the fruit of Russian 
Black sweet pepper was successively extracted and fractionated, and beside 
the anti-tumor activities, its effects were established against H. pylori. Those 
extracts and fractions eluted by less polar eluents, and which contain apolar 
components i.e. carotenoids, showed comparable antibacterial activities with 
metronidazole [27]. These fruits have a high carotenoid content, which 
compounds are well known of their antioxidant properties [28]. A high intake 
of carotenoids has been shown to prevent the development of H. pylori-
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associated diseases [29]. As free radicals play an important role in the 
pathogenesis of gastroduodenal mucosal inflammation, peptic ulcer disease 
and probably even gastric cancer, various micronutrients are considered to 
protect the gastric mucosa by scavenging the free radicals. 
 It was found that the crude extract of Salvia officinalis reduced                  
the minimum inhibitory concentration of aminoglycosides in vancomycin 
resistant enterococci, then the effective compound was isolated. Carnosol, the 
active compound showed weak antimicrobial activity and greatly reduced the 
MICs of various aminoglycosides [30]. Abietane diterpenoids extracted from 
Salvia sclarea were shown to be bacteriostatic and bactericid for the cultures 
of S. aureus and S. epidermidis strains, regardless to their antibiotic susceptibility 
profile [31]. 
 Plants may have direct antimicrobial effects and may act indirectly by 
stimulating the defence mechanisms, stimulating the immune response. 
Echinacea is a well-known immunostimulant and anti-inflammatory drug. 
The immunostimulant effect is complex. It has been reported that E. purpurea 
has an interferon (IFN)-like effect, activating macrophages, T-lymphocytes 
and inducing the production of cytokines. Low concentration of Echinacea 
extracts induce higher levels of cytokines (TNF-α, IL-1, IL-6, IL-10) in 
macrophages, which is consistent with an immune activated antiviral effect 
[32,33]. 
 
Reversal of bacterial resistance by plant derived compounds 
 
 Antibiotic resistance provides a great therapeutical and economic burden 
in the treatment of infectious diseases and it may threaten the success of 
antimicrobial chemotherapy. It is estimated that antibiotic resistance double 
hospital stay and morbidity. Single antibiotic resistance itself is a great 
problem, however the appearance of multiple antibiotic resistant (MDR) strains 
cause a more pronounced obstacle for patients and healthcare professionals 
[34,35].  
 Resistant strains appeared soon after the introduction of an antibiotic and 
initially showed up in hospitals, where most antibiotics were used, causing 
clinical difficulties for nosocomial treatment on a global scale. Antibiotic 
resistance has been unavoidable from an evolutionary perspective, since the 
antibiotic pressure provides the potential for resistant bacteria to acquire an 
important advantage. Discretionary use of antibiotics lead to the spread of 
resistant strains, which causes the most expressed problem at nosocomial 
circumstances, mainly in immunocompromized patients. Important contributing 
factors to community acquired infection with resistant bacteria may be the 
poor hand-hygiene among healthcare workers and device-associated infections. 
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Antibiotics can be disseminated into the environment from agricultural 
sources as well, of which importance has recently been recognized and 
studied extensively. Antibiotics are widely used as growth promoters in 
veterinary practice in sub-clinical concentrations and this poses a potential 
risk for the selection of resistant bacterial strains, which may be transmitted 
to humans. Since the growing rate of bacterial resistance is of great medical 
and public concern, there is an urgent need to develop appropriate methods 
and protocols to overcome or at least reduce the incidence and spread of 
resistant strains [36,37,38]. 
 The mechanisms of resistance show a versatile picture, however certain 
bacterial strains have intrinsic resistance against antimicrobial agents, 
acquired resistance against antimicrobial chemotherapy possess a larger risk 
of therapeutical failure. Antibiotic resistance in bacteria can be divided into 
the following major groups based on the mechanism involved: Resistance 
may develop due to the presence of an enzyme that inactivates (beta-
lactamases) or modifies the antibiotic (aminoglycoside, due to the presence of 
an alternative enzyme for that inhibited by the antibiotic), modification of the 
antibiotic-target, reduced permeability and active efflux may also lead to 
resistance [39]. 
 The genetic determinants encoding antimicrobial resistance can be 
located on the bacterial chromosome or on plasmids, which may replicate 
independently from the chromosome. Normally susceptible populations of 
bacteria may become resistant to antimicrobial agents through mutation and 
selection, or by acquiring from other bacteria the genetic information, that 
encodes resistance. The acquisition of such genetic elements may occur 
through transfer of genetic mechanisms i.e. conjugation, transduction and 
transformation [40]. These mechanisms are in the background of infectious 
resistance of bacteria. Development of novel antimicrobial agents or 
substances that target the resistance of bacteria on genetic or protein level 
would be a possible attempt to overcome the problem. Several in vitro studies 
prove that herbal medicines or plant-derived compounds may serve sources 
for this purpose.  
 Many attempts has been made to investigate the potential role of plant 
extracts and some active compounds for their efficacy to combat the 
problems of drug resistance in bacteria by reversal of resistance, efflux 
inhibition, inhibition of biofilm formations, interference in bacterial quorum 
sensing etc. Some of these fin dings are discussed below. 
 One attempt is the selective inhibition of efflux mechanisms related to 
antibiotic resistance in order to potentiate the chemotherapeutic agent. 
Martins et al found that the extract of Carpobrotus edulis is effective in this 
respect. The genus Carpobrotus is a perennial succulent horizontally low-
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growing sub-shrub. It is traditionally utilized for its medicinal properties: the 
leaf juice is used for a wide range of bacterial and fungal infections and in the 
treatment of sinusitis, diarrhoea, infantile eczema, tuberculosis and other 
internal chest conditions. The crude extract of the leaves was proved to have 
antibacterial effects against several human pathogenic bacteria. The methanol 
extract of that plant is able to enhance the killing activity of human peripheral 
blood monocyte-derived macrophages against intracellular S. aureus. It is 
hypothesised that it may be attributed to the ability of macrophages to 
concentrate the extract in vitro, which might be based on the inhibition of 
efflux functions [41,42,43,44]. 
 A single pump can provide bacteria with resistance to a wide array of 
chemically and structurally diverse compounds. Microbial efflux was first 
reported for the efflux of tetracycline by E. coli. Five major families of efflux 
transporters can be distinguished: the major facilitator superfamily, the 
resistance-nodulation-division superfamily, the small MDR family, the ATP 
binding cassette family and the multiple antibiotic and toxin extrusion family. 
However there does not exist a combination of antibiotic and efflux inhibitor 
in the treatment of infections, plant derived compounds seem to be potential 
drug candidates in this respect. The antihypertensive plant alkaloid reserpine 
was first isolated from the roots of Rauwolfia vomitoria and its efflux 
inhibitory effect was demonstrated on various bacterial strains. However, this 
compound seemed ideal as an MDR modifier according to in vitro studies, 
the further investigation of this substance is highly limited by its neurotoxic 
effects in the concentration of efflux inhibition [45]. There have also been a 
number of methoxylated flavones and isoflavones described as putative 
inhibitors of MDR pumps. These effects are mainly exhibited by potentiation 
and not by direct inhibition [46].  
 In several microbial infections, biofilm formation plays a major role in 
the ineffectivity of antibiotic therapy, therefore the inhibition of biofilm 
formation would be a possible approach to find resistance modifiers. Biofilm 
formation is generally regulated in a population-density dependent manner 
via quorum sensing. An important consequence of biofilm growth is the 
markedly enhanced resistance to antimicrobial agents where biofilm-associated 
microorganisms are estimated to be 50 to 500 times more resistant than their 
planktonic counterparts. (Figure 1.) 
 Quorum-sensing activities have been described for the sesquiterpenoid 
farnesol. In this role, farnesol produced extracellularly prevented the transition 
from yeast to hyphal growth in Candida albicans and greatly compromised 
biofilm formation by this fungus. Some studies indicated a possible interaction of 
farnesol with cell membranes of certain bacterial species including Streptococcus 
mutans. This natural compound has the potential to inhibit the development of  
Antimicrobial effects of essential oils  187 
 
Figure 1. Stages of biofilm formation. In certain microbial infections, biofilm formation 
plays an important role in the loss of activity of antimicrobial therapy, therefore the 
inhibition of quorum sensing mechanisms related to biofilm formation would serve a 
possible approach in the design of antibiotics with new targets. (http://biology. 
binghamton.edu/davies/images/biofilm.jpg). 
 
dental caries via the inhibition of biofilm formation. The use of the 
compound would be a novel approach in oral hygiene, since this compound 
does not necessarily have a major effect on the viability of the oral flora 
population, but rather it may disrupt the accumulation and the polysaccharide 
content of dental plaque related to this common oral disease [47]. By monitoring 
changes in the amount of K+ ions in the presence of terpene alcohols, the rate 
of leakage of the ion from the bacterial cells was found to increase with 
increasing concentrations of the compounds added. Farnesol is naturally 
found in the essential oil of citrus fruits and was shown to devoid of toxic 
effects and non-mutagenic in vitro and in vivo.  
 Inhibition of formation and accumulation of biofilm communities by 
affecting the synthesis of polysaccharides is an attractive route for preventing 
biofilm-related infections. Relatively low concentration of farnesol was sufficient 
to inhibit biofilm formation, as was shown by viability assays and fluorescence 
microscopy for both of MRSA and MSSA strains. The hydrophobic nature of 
farnesol favors its accumulation in the mambrane, possibly causing membrane 
leakage. It was also successful at enhancing the antibacterial efficacy of 
antibiotics to which S. aureus strains were somewhat susceptible. This ability of 
farnesol to sensitize S. aureus to such a heterogeneous group of antibiotics 
underlines the non-specific nature of this enhancing activity [48]. Farnesol may 
be a component of adjuvant therapy of skin infections [49,50,51]. 
 The Australian red macroalga Delisea pulchra produces a range of 
halogenated furanone compounds that display antimicrobial properties. It is 
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hypothesized that furanones of D. pulchra constitute a specific means of 
eukaryotic interference with bacterial signalling process via competing with 
the quorum-sensing signals. Some derivatives of these compounds were 
shown to repress quorum sensing in P. aeruginosa and reduce virulence 
factor expression [52,53]. 
 Resistance of enterococci is a great concern in public health, several 
strains exhibit multiple antibiotic resistance including that to both ampicillin 
and vancomycin. Flavonoids i.e. galangin and 3,7-dihydroxyflavone were 
shown to restore the vancomycin sensitivity of Enterococcus faecalis and            
E. faecium, by lowering the MICs to the level of vancomycin sensitive 
strains. It is suggested that the alternatively synthesized disaccharide peptide 
(ala-lac) production might be initially inhibited by the presence of flavonoid. 
It seems likely that in the presence of both sub-MIC levels of flavonoids and 
vancomycin that the production of disaccharide peptides ala-ala and ala-lac 
were inhibited and cell wall biosynthesis was interrupted as a result of 
cessation of peptidoglycan synthesis [54].  
 
Antibacterial effects of essential oils   
 
 The antiseptic properties of aromatic plants and their extracts have been 
recognised since antiquity and are still used in the medicine, food and 
cosmetic industry. There appears to be a revival in the use of traditional 
approach to protecting livestock and food from disease and spoilage in 
industrial countries. Bearberry (Arctostaphylos uva-ursi) and cranberry juice 
(Vaccinium macrocarpon) to treat urinary tract infections is reported in 
different manuals of phytotherapy, while species such as lemon balm 
(Melissa officinalis), garlic (Allium sativum) and tea tree (Melaleuca 
alternifolia) are described as broad-spectrum antimicrobial agents. These 
therapeutic effects can be generally attributed to the essential oils of these 
plants rather than their extracts [55]. Essential oils are generally isolated from 
non-woody plants by distillation methods, mainly by steam or hydrodistillation. 
Essential oils are usually made up of terpenoids, specifically monoterpenes 
and sesquiterpenes, but diterpenes may also be present and a variety of low 
molecular weight aliphatic hydrocarbons, acids, alcohols, aldehydes, acyclic 
esters or lactones, coumarines and homologues of phenylpropanoids. Most 
terpenes are derived from the condensation of branched five-carbon isoprene 
units and are categorized according to the number of these units present in the 
carbon skeleton [56]. The mechanism of action of terpenes is not fully 
understood, it is assumed that membrane disruption by the lipophilic 
components is involved in the antibacterial action. In vitro studies proved that 
increasing the hydrophilicity of kaurene diterpenoids by the addition of a 
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methyl group drastically reduced their antibacterial activities [57]. 
Terpenoids may serve as an example of lipid soluble agents which affect the 
activities of membrane-catalysed enzymes, for example their action on 
respiratory pathways. Certain components of essential oils can act as 
uncouplers, which interfere with proton translocation over a membrane 
vesicle and subsequently interrupt ADP phosphorylation. Specific terpenoids 
with functional groups, e.g. phenolic alcohols or aldehydes, also interfere 
with membrane-integrated or associated enzyme-proteins, stopping their 
production or activity [58]. The mode of action also depends on the 
microorganism and is mainly related to its cell wall structure. Gram-negative 
bacteria have intrinsic resistance against toxic components, since they have a 
permeability barrier against toxic agents. Hydrophobic macromolecules, such 
as essential oil constituents, are unable to penetrate the barrier. On the other 
hand, essential oils usually express low aqueous solubility, which prevents 
them from reaching a toxic level in cellular membranes [59]. In case of tea 
tree oil, the antimicrobial effect is based on the denaturation of membrane 
proteins, resulting in the outer membrane disruption, subsequent K+ leakage, 
respiration inhibition and cell lysis [60,61]. Essential oils are also able to 
inhibit the synthesis of DNA, RNA, proteins and polysaccharides in fungal 
and bacterial cells [62]. 
 Since in vitro tests also proved the efficacy of certain essential oils as 
resistance modulators, there is every likelihood that these plant secondary 
metabolites might be used in the clinical practice as complementary agents in 
the treatment of resistance bacterial infections. Nevertheless their antimicrobial 
action is based on non-specific mechanisms (i.e. membrane disruption), thus 
the clinical use might be limited to superficial infections.  
 
Antibacterial assays for essential oils 
 
 For the establishment of antimicrobial properties of essential oils, 
conventional methods of testing are usually applied. The agar diffusion and 
broth dilution methods are the most widely used. The assessments of 
antimicrobial activities by these methods are limited due to the volatility, 
water insolubility and complexity of essential oils. The agar diffusion method 
is not considered a perfect method for essential oils, as their volatile 
components are likely to evaporate with the dispersing solvent during the 
incubation time, while their poorly soluble components do not diffuse well in 
the agar broth, but it still remains the most common technique. The inhibitory 
effect of essential oils in the test tubes and microtitre plates is measured 
turbidimetrically or with the count plate method. In experiments testing the 
essential oils activity towards microorganisms, the result depends mainly on 
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the method used, however a number of other factors should also be 
considered. Culture conditions are predominantly influencing the study; therefore 
these should be precisely being stated in reports.  [58].  
 
Antimicrobial properties of selected essential oil producing 
herbs  
 
 Peppermint (Mentha piperita) is a perennial flowering member of the 
mint family. The medicinal use of peppermint and other mint plants date back 
to the ancient Greece, where peppermint leaf was used internally as a 
digestive aid and for the management of gallbladder disease and it was also 
used in the treatment of upper respiratory diseases and for cough. Extracts of 
peppermint are used as flavouring in many alimentary and cosmetic products 
and in over the counter medicines. Peppermint oil has become a popular 
treatment for a variety of conditions. In vitro research shows peppermint oil 
to be effective in relaxing gastrointestinal smooth muscle. This finding has 
led to the popularity of enteric-coated peppermint formulations [63]. Since 
essential oils were found to exert antimicrobial effect on various bacterial 
strains in vitro, the beneficial effects may be partly attributed to this activity 
[64,65]. Studies examining the effect of peppermint oil on bowel motility 
have shown that mechanisms may include calcium channel blocking on a 
local level, causing smooth muscle relaxation [66,67]. Peppermint oil may 
reduce spasm during endoscopies and barium enema [68,69,70]. The antibacterial 
effect of peppermint oil can be used in those conditions which are in relation 
with the bacterial overgrowth of the small intestine. A number of functional 
somatic disorders are included like irritable bowel syndrome, fibromyalgia 
and chronic fatigue syndrome. In these conditions, peppermint oil preparations 
seem efficient to alleviate the symptoms [71,72].  
 The antimicrobial effects of peppermint oil and its components have been 
proved in several studies. The MIC values of the oil is relatively high (may 
reach 5.0 mg/mL depending on the source), therefore the medicinal use of the 
oil is limited [73]. Due to its toxicity, the external use of the oil would be 
preferable, but successful internal application was reported in enteric-coated 
form. Peppermint oil and its main constituent menthol was described as 
possible agent in reversal of multidrug resistance in bacteria via their plasmid 
curing effects. Bacterial plasmids may carry resistance genes for different 
antibiotics and structurally unrelated chemicals. These plasmids can be 
transferred by conjugation between different bacterial strains or genera, 
which are a major cause of the spread of multiple resistance to antibiotics of 
bacteria. The inhibition of this process by the elimination of resistance-gene 
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carrying plasmids seems a promising perspective to overcome the problem. 
Molnar et al investigated a great number of chemical agents, predominantly 
tricyclic antipsychotic drugs and carried out a systematic assay in order to 
find structure-activity relationship in the antiplasmid activities of the 
investigated substances and it has been proposed that the HOMO orbital 
energy, the conjugated π-electron system of the tricyclic skeleton and the 
symmetric π-electron distribution to the L-molecular region and the 
superdelocalizability of the π-electron system on 10, 12, 13 atoms have 
special importance in the antiplasmid activity [74,75,76]. Promethazine was 
one of the most effective plasmid eliminators and was tested in vivo studies 
as well. Promethazine in combination with gentamycin reduced the number 
of recurrences in urinary tract infections as compared with the control 
(gentamycin only) group in children with frequently recurring pyelonephritis 
and had beneficial effects in urinary tract infections in adult patients 
[77,78,79,80]. Peppermint oil and menthol, the major component was tested 
for plasmid curing activity in in vitro experiments on the metabolic plasmid 
of E. coli F’lac K12 LE140. The plasmid curing activities were relatively 
high (Table 1.) [65]. 
 
Table 1. Antiplasmid activities of peppermint oil and menthol. The plasmid curing 
activities are designated in percentage. 
 
Sample 
Concentration 
(mg/ml) 
Bacterial growth after 
24 h x108 CFU/5 ml 
Plasmid 
elimination 
(%) 
MTY Control 0 0 - 
Promethazine 0.04 36.0 0.0 
 0.05 24.5 0.1 
 0.06 3.3 15.0 
 0.07 2.3 82.0 
 0.08 2.0 55.9 
 0.09 0.4 2.5 
 0.10 - - 
Peppermint oil 0.18 21.6 0 
 0.27 5.3 0.4 
 0.36 2.5 2.9 
 0.45 1.3 9.0 
 0.54 0.4 37.5 
 0.63 - - 
Menthol 0.250 3.5 7.1 
 0.275 5.3 82.0 
 0.300 1.5 74.0 
 0.325 3.1 96.0 
 0.350 1.3 64.0 
 0.375 3.9 8.7 
 0.400 - - 
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Figure 2. Plasmid elimination of the F’lac metabolic plasmid of E. coli K12 LE 140. 
Bacteria with functioning plasmid form dark colonies on the surface of eosine 
methylene blue agar, while those cells, of which F’lac plasmid has been eliminated 
develop transparent colonies due to the loss lactose fermentation. 
 
 Garlic (Allium sativum L.) has had an important dietary and medicinal role 
for centuries. Most of its prophylactic and therapeutic effects are ascribed to 
specific oil- and water-soluble organosulfur compounds, which are responsible 
for the typical odour and flavour of garlic. During crushing or cutting the clove, 
the odourless amino acid alliin is cleaved by the enzyme allinase to yield allicin 
and other thiosulfinates that are the source of the characteristic odour of garlic. 
The crude extracts of garlic exhibit a broad antimicrobial spectrum against gram-
positive and gram-negative bacteria.[81,82]  
 Gastric cancer is a major neoplastic diseases on a global scale. 
Helicobacter pylori is implicated in the aetiology of the development of the 
disease. It has been revealed that the incidence of stomach cancer is lower in 
individuals with a high intake of garlic vegetable. In vitro studies proved the 
anti-Helicobacter properties of garlic, therefore we may conclude that the 
lower incidence can be attributed to the antibacterial effect of the higher 
garlic intake, however there have not been made a sufficient number of 
randomized clinical trials [82]. 
 Thiosulfonates play an important role in the antibacterial activity of 
garlic. It was shown that the antimicrobial activity of garlic is completely 
abolished when the thiosulfinates are removed from the extract. The major 
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volatile component responsible for the antimicrobial effect is allicin.                 
The antibacterial effect of allicin is of a broad spectrum, even resistant 
bacterial strains e.g. MRSA, MDR enterotoxigenic strains (ETEC, Enterococci, 
Shigellae) were found to be sensitive to allicin. Allicin also had an in vivo 
antibacterial activity against S. flexneri when tested in the rabbit model of 
experimental shigellosis [83]. The mechanism by which allicin exert its 
action is presumably based on the rapid reaction with thiol groups of thiol-
containing enzymes. It was also found in in vitro assays that allicin exhibits 
its activity via immediate and total inhibition of RNA synthesis, although 
DNA and protein syntheses are also partially inhibited, suggesting that RNA 
is the primary target [84].  
 Australian tea tree (Melaleuca alternifolia) lives on low-lying, swampy 
coastal ground in New South Wales in Australia and unlike several other 
Melaleuca species it does not occur naturally outside Australia. The essential 
oil of that plant is employed largely for its antimicrobial properties. Tea tree 
oil (TTO) is incorporated as active ingredient in many topical formulations 
used to treat cutaneous infections. The earliest reported use of M. alternifolia 
plant that presumably exhibited antibacterial activity was the traditional use 
by Australian aboriginals in New South Wales for coughs and colds. Several 
in vitro studies proved the antimicobial properties of TTO against gram-
positive and gram-negative bacterial strains [85,86,87,88]. The activity of 
TTO against antibiotic-resistant bacteria has attracted considerable interest, 
with methicillin-resistant Staphylococcus aureus receiving the most attention 
so far. Subsequent reports on the susceptibility of MRSA to TTO have not 
shown great differences compared to antibiotic-sensitive organisms [89]. 
Despite major advances in wound management, infection still remains an 
important factor in wound healing. In burns, majority of burns are due to 
complications with sepsis resulting from wound infection. A considerable 
proportion of wound become colonised by resistant strains of S. aureus. An 
in vitro study highlights the potential use of TTO impregnaterd dressings for 
treating wounds infected with MRSA [90]. The mechanism of TTO against 
microorganisms is partly elucidated. Via disruption of membrane integrity, it 
is able to permeabilize model liposomal membranes, and in bacterial cells 
inhibits respiration. Treatment of S. aureus with TTO resulted in leakage of 
K+ ions, sensitized bacteria to sodium chloride and produced morphological 
changes apparent electron microscopy, but not whole-cell lysis [91].                 
In contrast with the absence of whole-cell lysis in S. aureus, lysis occurs in  
E. coli after the treatment with TTO and this effect is further exacerbated by 
co-treatment with EDTA. All of these effects confirm that TTO compromises 
the structural and functional integrity of bacterial membranes. It has also 
been reported that the susceptibility of bacteria may differ in different growth 
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phases, which suggests that in the effects of TTO targets other than the cell 
membrane may be involved [92].  
 In parallel with the characterization of in vitro antimicrobial activity of 
TTO, the clinical efficacy of the oil has also been the subject of investigation. 
In a single-blind randomized trial, the 5% lotion of tea tree oil (TTO) and 
benzoyl peroxide (control) were investigated in the treatment of acne. 
However, the benzoyl peroxide group showed a more rapid remission, the 
skin discomfort reported during the trial was less frequent in the TTO group 
[93]. A combination of a 4% tea tree oil nasal ointment and 5% TTO body 
wash was compared with a standard 2% mupirocin nasal ointment and 
triclosan body wash for the eradication of ethicillin resistant S. aureus 
carriage. TTO combination appeared to perform better than the standard 
combination [94]. In a randomized controlled trial of tea tree topical 
preparations versus standard preparations (mupirocin nasal ointment, 
chlorhexidine gluconate soap and silver sulfadiazine cream) were studied. 
Mupirocin was significantly more effective at clearing nasal carriage of MRSA 
than tea tree cream, but Tea tree treatment was more effective than chlorhexidine 
and silver sulfadiazine at clearing superficial skin sites and lesions. Since tea tree 
preparation was well tolerated by the treated patients, it may considered in 
regimens for eradication of MRSA carriage [95]. A patient with MRSA 
osteomyelitis was reported to have alternative anti-inflammatory therapy of a 
TTO preparation. During treatment, percutaneous TTO containing calcium 
sulphate pellets were given to the bone. Over a three-month period, the symptoms 
resolved with a healing response on X-ray [96]. 
 Thyme is stated to possess carminative, antispasmodic, antitussive, 
expectorant, secretomotor, bactericidal, anthelmintic and astringent properties. 
Due to its antimicrobial properties, thyme oil is considered a potent food 
preservative. It has antilisterial activity in relatively low concentration.        
The effects on the bacterial cells were examined by electron microscopy and the 
following findings were taken: the bacterial cells shrank, cell wall exhibited 
budding scars and degenerative changes showing splitting of the wall layers. 
Lack of cytoplasm and cell membrane disruption was evident at an early stage. 
These results on the mechanism of action of thyme oil on the inactivation of       
L. monocytogenes will help in the development or modification of the processing 
conditions, or the implementation of a new preservation factor to complement 
those already employed in food preservation and safety [97,98]. 
 Contamination of food comodities with aflatoxin resulting from fungal 
attack can occur before, after and during the harvest and storage operations. 
One of the characteristics of aflatoxin deactivation is that it should destroy 
the mycelia and spores of the toxic fungi, which may proliferate under 
favorable conditions. The essential oils of thymus species seem good candidates 
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for that purpose. In an in vitro study, the essential oil-related inhbition in 
mycelial growth was observed to be associated with significantly decreased 
levels of aflatoxin production. 8- and 4-fold dilutions of the essential oils of 
T. eriocalyx and T. x-porlock are effective in complete retardation of fungal 
growth respectively and a somewhat lower concentrations are suficient to 
significantly inhibit aflatoxin production. Contribution of thymol to the 
positive results seems to be significant [99]. 
 Origanum vulgare is a well known spice mainly in the Mediterraneum. 
Recently, origanum essential oil has been studied as a potential natural 
preservative in food manufacturing. Origanum essential oil exerts antimicrobial 
effect via cell membrane damage, with envelope disruption, formation of blebs 
and lack of cytoplasmic material. These alterations correlate with the ability of 
hydrocarbons to interact with hydrophobic structures, like bacterial membranes. 
These findings are based on investigations of E. coli and S. aureus by 
transmission electron microscopy, which allows to study the possible bacterial 
ultrastructural alterations [100]. 
 
Antimicrobial activities of individual oil components 
 
 Essential oils are mainly composed of terpenoids: monoterpenes and 
sesquiterpenes. Terpenes have been reported to be very active against bacteria. 
Many essential oil components are chiral compounds. The enantiomers very 
often show different biological activity. (+)-pinene and (-)-pinene serve a 
good example, since these enantiomers act differently: (+)-pinen was found 
to exert more pronounced antimicrobial effect on different bacterial and 
fungal strains [58]. 
 Carvacrol is one of the most common essential oil components which 
exert antibacterial effects, it is the major component of oregano and thyme. 
Carvacrol was investigated in E. coli O157:H7 ATCC 43895 for its effects on 
the protein synthesis. The presence of 1mM carvacrol during overnight 
incubation caused the bacterial strain to produce significant amounts of heat 
shock protein 60 (HSP60) and inhibited the flagellin synthesis highly 
significantly causing cells to be aflagellate and therefore nonmotile [101]. 
Addition of carvacrol of the culture of B. cereus results in an increase of 
membrane fluidity by changing their fatty acid and head-group composition. 
Carvacrol also caused depletion of the intracellular ATP pool and an 
increased permeability of the cell membrane for K+ upon exposure to 
carvacrol. K+ plays a role in the activation of cytoplasmic enzymes, the 
maintenance of turgor pressure, and possibly the regulation of the 
cytoplasmic pH. Different studies showed that an efflux of K+ is a first 
indication of membrane damage in bacteria.  [102,103].  
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 The antifungal activities of carvacrol and eugenol were investigated in 
immunosuppressed rats for the treatment of oral candidiasis induced by 
Candida albicans. The anticandidal activity was established by microbiological 
and hystopathological methods. Nystatin was used as positive control. 
Microbiologically carvacrol and eugenol significantly reduced the number of 
colony forming units sampled from the oral cavity of rats treated. Histologically, 
the untreated control animals showed numerous hyphae on the epithelium of the 
dorsal surface of the tongue. In contrast, no hyphal colonisation was seen in 
carvacrol-treated animals, while in rats treated with eugenol, only a few focalized 
zones of the dorsal surface of the tongue was occupied by hyphae. Carvacrol and 
eugenol could be proposed as therapeutic agents in the treatment of oral 
candidiasis. [104] 
 Elastase, a serine proteinase released by human neutrophils, can degrade 
a wide variety of biomacromolecules including elastin and is considered a 
biomarker of inflammatory diseases. Thymol, which is a potent antibacterial 
components of thyme essential oil can approach the ion channel proteins 
through the lipid phase of the membrane due to its hydrophobic nature and 
alters the local environment of calcium channels inhibiting capacitative 
calcium entry. This leads to a corresponding reduction in elastase. The 
antimicrobial, antioxidant and anti-elastase properties of thymol may have helpful 
effects in controlling the inflammatory processes present in many infections. 
[105]  
 In a non-randomized clinical trial the extract of Thea assamica was 
tested on patients with impetigo contagiosa. The extract was as effective as 
the antibiotic control [106]. The essential oil of Chenopodium botrys has 
antibacterial activity on selected gram-positve and Gram-negative bacterial 
strains, furthermore the extract was proved to have antifungal activity against 
the ATCC strains of Aspergillus niger and Candida albicans [107]. 
 
Summary 
 
 There is resurgence in the use of herbal medicines worldwide. An 
estimated one third of adults in the Western world use alternative therapies, 
including herbs. These herbs may be used either in their primary forms or 
combined in mixtures. In contrast to chemical drugs, herbs have sometimes 
been claimed to be non-toxic, because of their natural origin and long-term 
use as folk medicines. However, problems may arise due to intrinsic toxicity, 
adulteration, substitution, contamination, misidentification, drug-herb interactions 
and lack of standardization [108]. This unfavourable fact urges the study of 
medicinal plants and plant derived compounds used in medicine and food 
industry. 
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 A great deal of essential oils has beneficial properties, such as antioxidant, 
anti-inflammatory and antimicrobial properties. The main constituents of          
esential oils- mono- and sesquiterpenes including carbohydrates, alcohols, ethers, 
aldehydes and ketones – are responsible for the fragrant and biological properties 
of aromatic and medicinal plants. Despite the development of antibiotics, 
bacterial and fungal infections are still a major issue in medicine, and the 
presence of multidrug resistant strains poses a great challenge. Recently, there has 
been a growing interest in natural products due to their availability and better 
biodegradebility. In this regard, essential oils may offer a great potential and these 
plant secondary metabolites may be used as alternative anti-infective and food 
preservatives [58]. The use of essential oils in the treatment of infectious diseases 
is limited due to their toxicity but in the treatment of superficial infections or 
respiratory diseases via aromatherapy may be possible applications. In food 
industry, the shelf-life of foods is often extended by the addition of antibacterial 
chemicals, but there is a need for preservatives, which do not alter the 
organoleptic properties of foods. Some of the essential oils seem good candidate 
for that purpose to prevent food spoilage as well.  
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